HomeRLAY • NASDAQ
add
Relay Therapeutics Inc
Previous close
$4.12
Day range
$3.97 - $4.09
Year range
$1.78 - $8.32
Market cap
687.92M USD
Avg Volume
1.60M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Revenue | 677.00K | — |
Operating expense | 13.75M | -31.71% |
Net income | -70.38M | 23.68% |
Net profit margin | -10.40K | — |
Earnings per share | -0.41 | 40.58% |
EBITDA | -73.54M | 33.60% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 656.78M | -4.60% |
Total assets | 728.84M | -5.66% |
Total liabilities | 63.18M | -30.42% |
Total equity | 665.66M | — |
Shares outstanding | 172.41M | — |
Price to book | 1.06 | — |
Return on assets | -24.39% | — |
Return on capital | -25.39% | — |
Cash Flow
Net change in cash
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Net income | -70.38M | 23.68% |
Cash from operations | -55.26M | 16.06% |
Cash from investing | 75.15M | 64.97% |
Cash from financing | 653.00K | -57.65% |
Net change in cash | 20.54M | 209.59% |
Free cash flow | -27.55M | 6.75% |
About
Founded
2015
Website
Employees
197